Iofina plc (FRA:IF7)

Market Cap	57.13M +11.4%
Revenue (ttm)	49.09M +11.5%
Net Income	4.10M +33.5%
EPS	0.02 +39.4%
Shares Out	n/a
PE Ratio	13.92
Forward PE	12.22
Dividend	n/a
Ex-Dividend Date	n/a

Volume	151
Average Volume	8
Open	0.2560
Previous Close	0.2460
Day's Range	0.2560 - 0.3160
52-Week Range	0.2140 - 0.3500
Beta	n/a
RSI	65.63
Earnings Date	May 11, 2026

About Iofina

Iofina plc, together with its subsidiaries, explores for, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations in North America, Asia, South America, Europe, and internationally. The company offers iodides, chlorides, and fluorides; and iodine used for animal care and health, biocides and catalysts, disinfectants, fungicide, specialty intermediates, mineral separators, thyroid health, wound healing, diagnostic imaging, iofina logo gray sun 5, preservatives and sanitizers, semiconductor etcha...

• Industry: Crude Petroleum and Natural Gas
• Founded: 2005
• Employees: 116
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: IF7

Financial Performance

In 2024, Iofina's revenue was $54.47 million, an increase of 8.85% compared to the previous year's $50.04 million. Earnings were $2.92 million, a decrease of -55.55%.

Financial numbers in USD